ALBERTDAVD vs SANOFICONR: Stock Comparison

ALBERT DAVID vs SANOFI CONS HEALTHC IND LUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

SANOFI CONS HEALTHC IND L is the larger company by market capitalisation. ALBERT DAVID shows a lower P/E, while SANOFI CONS HEALTHC IND L shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALBERTDAVD leads 4; SANOFICONR leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALBERTDAVDSANOFICONR

Valuation lens

What price are you paying?

Market CapContext only
₹493 Cr
₹9,719 Cr
P/E RatioALBERTDAVD has the lower reading
20.47x
36.36x
P/B RatioALBERTDAVD has the lower reading
1.18x
27.8x
EPSALBERTDAVD has the higher reading
₹56.07
₹29.87
Book ValueContext only
₹686.04
₹166.73
Dividend YieldSANOFICONR has the higher reading
0.58%
1.81%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SANOFICONR is the larger company
₹9,719 Cr vs ₹493 Cr
P/E Ratio
ALBERTDAVD has a lower P/E
20.47x vs 36.36x
P/B Ratio
ALBERTDAVD has a lower P/B
1.18x vs 27.8x
EPS
ALBERTDAVD has higher earnings per share
₹56.07 vs ₹29.87
Dividend Yield
SANOFICONR has a higher dividend yield
1.81% vs 0.58%
Revenue Growth (TTM YoY)
SANOFICONR has faster revenue growth
32.8% vs 14.6%
EPS Growth (TTM YoY)
SANOFICONR has faster EPS growth
35.7% vs 0%
Qtr Sales Growth
SANOFICONR has stronger quarterly sales growth
2.84% vs -69.62%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALBERTDAVDSANOFICONR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALBERTDAVDSANOFICONR
Live Price₹860.25₹4,201.7
Day Change-1.14%-0.09%
Volume3,3396,432
52-Week High₹931.85₹5,357
52-Week Low₹579.9₹3,975
Distance from 52W High-7.68%-21.57%

Valuation

MetricALBERTDAVDSANOFICONR
Market Cap₹493 Cr₹9,719 Cr
P/E Ratio20.47x36.36x
P/B Ratio1.18x27.8x
EPS₹56.07₹29.87
Book Value₹686.04₹166.73
Dividend Yield0.58%1.81%

Growth

MetricALBERTDAVDSANOFICONR
Revenue Growth (TTM YoY)14.6%32.8%
EPS Growth (TTM YoY)0%35.7%
Qtr Sales Growth-69.62%2.84%
Qtr Profit Growth2,240.75%1.47%

Profitability & Leverage

MetricALBERTDAVDSANOFICONR
ROE-0.38%67.16%
ROCE-2.14%2,813.76%
Net Margin-0.45%27.58%
Operating Margin0.95%37.04%
Debt to Equity0.07x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALBERTDAVDSANOFICONR
Promoter Holding62.24%
FII Holding0.57% 0.01 pp2.6% 0.16 pp
DII Holding1.64% 0.02 pp17.86% 0.29 pp
Public Holding35.56% 0.04 pp8.27% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALBERT DAVID and SANOFI CONS HEALTHC IND L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.